The prevalence of age-related maculopathy: the visual impairment project.
about
Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysisParainflammation, chronic inflammation, and age-related macular degenerationImpact of loading phase, initial response and CFH genotype on the long-term outcome of treatment for neovascular age-related macular degenerationSimulating prosthetic vision: Optimizing the information content of a limited visual display.Causes of low vision and blindness in rural Indonesia.New treatments in age-related macular degeneration.Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM Study.Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina StudyPrevalence of early and late age-related macular degeneration in India: the INDEYE study.An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism.The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.Aflibercept for the treatment of age-related macular degeneration.Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population.A circulating microrna profile is associated with late-stage neovascular age-related macular degenerationWorld blindness: a 21st century perspective.Strategies for mapping susceptibility genes in age-related maculopathy.The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning.Genetics of age-related macular degeneration: current concepts, future directions.Association between CFH Y402H polymorphism and age related macular degeneration in North Indian cohort.How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study.Assessment of Neutrophil/Lymphocyte Ratio in Patients with Age-related Macular Degeneration.Quality of life with macular degeneration: perceptions of patients, clinicians, and community members.Association of complement factor H gene polymorphisms with age-related macular egeneration susceptibility.An association between polymorphism of the heme oxygenase-1 and -2 genes and age-related macular degeneration.Associated factors for age related maculopathy in the adult population in China: the Beijing eye studyPrevalence of age-related macular degeneration in the Republic of Ireland.Artificial means for restoring visionAssociation of Combined Complement Factor H Y402H and ARMS/LOC387715 A69S Polymorphisms with Age-related Macular Degeneration: A Meta-analysis.Serum MicroRNAs as Potential Biomarkers of AMDAssociation of combined cigarette smoking and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: A meta-analysis.Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years.Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.Circadian rhythm dysfunction in glaucoma: A hypothesis.Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration.Association of Htra1 gene polymorphisms with the risk of developing AMD in Iranian populationEye disorders in old peopleChlamydia pneumoniae and age-related macular degeneration: a role in pathogenesis or merely a chance association?Age-related macular degeneration: a target for nanotechnology derived medicines
P2860
Q24569500-BAF5E247-0220-49E6-A39B-498D765A043BQ26796268-ACBA2AB0-7F03-4C2A-80AF-BC0D4DA4EA7EQ28728817-5D27D8AE-9D51-4560-8DB5-2338B6EADE6DQ28742406-540D0348-7353-40DC-9890-13DF7BA1D2F8Q30977507-65DD5C21-0228-4D66-8A93-22C3C1AE76A7Q31004243-D9EA6090-BBB8-40E1-B7AC-CC01D75BE2D7Q33263472-4ED5943A-9AE4-4671-9BAE-05846DD37232Q33395089-B9CD35F6-847D-452D-9693-7C4ADD247785Q33739809-C86377D3-806E-4DF7-8480-B04132E464B6Q33845354-0BAF143F-6DBE-43BF-A889-C53B15304322Q33845500-1EBA8118-3D99-47C7-B0B1-0DB7A979BD03Q33855388-AA748E86-96CB-427C-8389-2CF5D90FC04AQ33939215-BA2DBC86-57DA-45DF-A0C9-686AFC51BCA1Q34092050-2547BA26-A472-4D83-BB8E-2E7CEA63F65CQ34156202-6A746534-877F-46B7-A599-66D100FCAADDQ34164449-D8542E5C-8329-4232-8944-14C71B30996AQ34307048-E3EE347B-01F9-4D0A-ACBA-820A711AB1C3Q34429948-92478771-7D6F-428E-BA44-6D5D44335153Q34565573-DEB3813F-138A-415D-AEB5-AF8CB3B59722Q34906472-555C0B10-1D35-4256-B515-86F9D680BD32Q35070975-281CF125-7199-4454-84D7-CD1C6AA89C28Q35085936-91A02071-6C99-4946-831B-86B9595DABA9Q35200030-5738B46F-4145-4EB6-9276-6FF12E37EA5DQ35590440-822F8F68-52F4-4704-8CAB-2B00F32178CDQ35632365-58B23787-E18A-46AD-9ACC-38C73533FAA6Q35730294-F5832B73-8F2B-487B-AD81-DAE80A42B8F2Q35762418-69DDEE3F-9779-45FC-82B9-13F6CA00F904Q35899608-F785D7A9-5DDA-4BA7-89F6-BEAF8D79D62DQ35997009-92A0B76F-EC9C-40D4-BF78-C3308BE3BF56Q36042938-A8FDA551-D1EB-4946-83D2-129A76B53A1EQ36078404-07201D1A-5F71-40CF-8393-F246396A6A35Q36251083-3B46E503-5B6B-4D23-B03D-58C62F5B24E3Q36313773-F9F168EB-F334-4321-81E9-3F5DB3AC70CCQ36350405-A39B222D-7FD8-4679-BBEA-170D2E64B3E6Q36473589-138973CD-B66A-46C8-8FB3-F6E0B033DA17Q36564570-EF65E727-8E54-4448-9068-D615E9AB217FQ36589584-7AE0B103-21C8-463D-84D9-90BD93442256Q36648305-0804592E-72B4-4F9D-BB26-7AE6940D4B37Q36735756-0F550DA0-65B9-4619-81A3-CEB597FE3503Q36920435-F7080046-721B-4448-92BC-458CB78F45D3
P2860
The prevalence of age-related maculopathy: the visual impairment project.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
The prevalence of age-related maculopathy: the visual impairment project.
@en
The prevalence of age-related maculopathy: the visual impairment project.
@nl
type
label
The prevalence of age-related maculopathy: the visual impairment project.
@en
The prevalence of age-related maculopathy: the visual impairment project.
@nl
prefLabel
The prevalence of age-related maculopathy: the visual impairment project.
@en
The prevalence of age-related maculopathy: the visual impairment project.
@nl
P2093
P1433
P1476
The prevalence of age-related maculopathy: the visual impairment project.
@en
P2093
Mitchell P
VanNewkirk MR
P304
P356
10.1016/S0161-6420(00)00175-5
P577
2000-08-01T00:00:00Z